1
|
Basten M, Aulenbacher K, Barth W, Burandt C, Dziuba F, Gettmann V, Kürzeder T, Lauber S, List J, Miski-Oglu M, Yaramyshev S. Continuous wave interdigital H-mode cavities for alternating phase focusing heavy ion acceleration. Rev Sci Instrum 2022; 93:063303. [PMID: 35778048 DOI: 10.1063/5.0094859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 06/06/2022] [Indexed: 06/15/2023]
Abstract
In the future, a new superconducting (SC) continuous wave (CW) high intensity heavy ion HElmholtz LInear ACcelerator (HELIAC) should provide ion beams with maximum beam energy above the Coulomb barrier for the Super Heavy Element program at GSI (Gesellschaft für Schwerionenforschung, in Engl.: Association for Heavy Ion Research). The HELIAC consists of a SC main accelerator supplied by a normal conducting injector, which comprises an electron cyclotron resonance ion source, a radio-frequency quadrupole, and two separate interdigital H-mode drift-tube linear accelerator cavities, based on an Alternating Phase Focusing (APF) scheme. Together, both cavities will accelerate ions from 300 to 1400 keV/u with only one external quadrupole triplet for transverse focusing in between. Due to the demanding requirements of the APF concept on the voltage distribution along the beam axis on the one hand and the CW operation on the other hand, the optimization of each cavity concerning RF, mechanical, and thermal properties is crucial for the successful operation of the HELIAC injector.
Collapse
Affiliation(s)
- M Basten
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - K Aulenbacher
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - W Barth
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - C Burandt
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - F Dziuba
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - V Gettmann
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - T Kürzeder
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - S Lauber
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - J List
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - M Miski-Oglu
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - S Yaramyshev
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| |
Collapse
|
2
|
Andreev V, Arratia M, Baghdasaryan A, Baty A, Begzsuren K, Belousov A, Bolz A, Boudry V, Brandt G, Britzger D, Buniatyan A, Bystritskaya L, Campbell AJ, Cantun Avila KB, Cerny K, Chekelian V, Chen Z, Contreras JG, Cunqueiro Mendez L, Cvach J, Dainton JB, Daum K, Deshpande A, Diaconu C, Eckerlin G, Egli S, Elsen E, Favart L, Fedotov A, Feltesse J, Fleischer M, Fomenko A, Gal C, Gayler J, Goerlich L, Gogitidze N, Gouzevitch M, Grab C, Greenshaw T, Grindhammer G, Haidt D, Henderson RCW, Hessler J, Hladký J, Hoffmann D, Horisberger R, Hreus T, Huber F, Jacobs PM, Jacquet M, Janssen T, Jung AW, Jung H, Kapichine M, Katzy J, Kiesling C, Klein M, Kleinwort C, Klest HT, Kogler R, Kostka P, Kretzschmar J, Krücker D, Krüger K, Landon MPJ, Lange W, Laycock P, Lee SH, Levonian S, Li W, Lin J, Lipka K, List B, List J, Lobodzinski B, Malinovski E, Martyn HU, Maxfield SJ, Mehta A, Meyer AB, Meyer J, Mikocki S, Mondal MM, Morozov A, Müller K, Nachman B, Naumann T, Newman PR, Niebuhr C, Nowak G, Olsson JE, Ozerov D, Park S, Pascaud C, Patel GD, Perez E, Petrukhin A, Picuric I, Pitzl D, Polifka R, Preins S, Radescu V, Raicevic N, Ravdandorj T, Reimer P, Rizvi E, Robmann P, Roosen R, Rostovtsev A, Rotaru M, Sankey DPC, Sauter M, Sauvan E, Schmitt S, Schmookler BA, Schoeffel L, Schöning A, Sefkow F, Shushkevich S, Soloviev Y, Sopicki P, South D, Spaskov V, Specka A, Steder M, Stella B, Straumann U, Sun C, Sykora T, Thompson PD, Traynor D, Tseepeldorj B, Tu Z, Valkárová A, Vallée C, Van Mechelen P, Wegener D, Wünsch E, Žáček J, Zhang J, Zhang Z, Žlebčík R, Zohrabyan H, Zomer F. Measurement of Lepton-Jet Correlation in Deep-Inelastic Scattering with the H1 Detector Using Machine Learning for Unfolding. Phys Rev Lett 2022; 128:132002. [PMID: 35426724 DOI: 10.1103/physrevlett.128.132002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 12/20/2021] [Accepted: 02/25/2022] [Indexed: 06/14/2023]
Abstract
The first measurement of lepton-jet momentum imbalance and azimuthal correlation in lepton-proton scattering at high momentum transfer is presented. These data, taken with the H1 detector at HERA, are corrected for detector effects using an unbinned machine learning algorithm (multifold), which considers eight observables simultaneously in this first application. The unfolded cross sections are compared with calculations performed within the context of collinear or transverse-momentum-dependent factorization in quantum chromodynamics as well as Monte Carlo event generators.
Collapse
Affiliation(s)
- V Andreev
- Lebedev Physical Institute, Moscow, Russia
| | - M Arratia
- University of California, Riverside, California 92521, USA
| | | | - A Baty
- Rice University, Houston, Texas 77005-1827, USA
| | - K Begzsuren
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - A Belousov
- Lebedev Physical Institute, Moscow, Russia
| | - A Bolz
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - V Boudry
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Brandt
- II. Physikalisches Institut, Universität Göttingen, Göttingen, Germany
| | - D Britzger
- Max-Planck-Institut für Physik, München, Germany
| | - A Buniatyan
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - L Bystritskaya
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - A J Campbell
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - K B Cantun Avila
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán, México
| | - K Cerny
- Joint Laboratory of Optics, Palacký University, Olomouc, Czech Republic
| | - V Chekelian
- Max-Planck-Institut für Physik, München, Germany
| | - Z Chen
- Shandong University, Shandong, People's Republic of China
| | - J G Contreras
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán, México
| | | | - J Cvach
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - J B Dainton
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - K Daum
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | - A Deshpande
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C Diaconu
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - G Eckerlin
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Egli
- Paul Scherrer Institut, Villigen, Switzerland
| | - E Elsen
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Favart
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A Fedotov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - J Feltesse
- Irfu/SPP, CE Saclay, Gif-sur-Yvette, France
| | - M Fleischer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - A Fomenko
- Lebedev Physical Institute, Moscow, Russia
| | - C Gal
- Stony Brook University, Stony Brook, New York 11794, USA
| | - J Gayler
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Goerlich
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | | | - M Gouzevitch
- Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - C Grab
- Institut für Teilchenphysik, ETH, Zürich, Switzerland
| | - T Greenshaw
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - D Haidt
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - R C W Henderson
- Department of Physics, University of Lancaster, Lancaster, United Kingdom
| | - J Hessler
- Max-Planck-Institut für Physik, München, Germany
| | - J Hladký
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - D Hoffmann
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | | | - T Hreus
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - F Huber
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - P M Jacobs
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Jacquet
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - T Janssen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A W Jung
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Jung
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M Kapichine
- Joint Institute for Nuclear Research, Dubna, Russia
| | - J Katzy
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - C Kiesling
- Max-Planck-Institut für Physik, München, Germany
| | - M Klein
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - C Kleinwort
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - H T Klest
- Stony Brook University, Stony Brook, New York 11794, USA
| | - R Kogler
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - P Kostka
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - J Kretzschmar
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - D Krücker
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - K Krüger
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M P J Landon
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - W Lange
- Deutsches Elektronen-Synchrotron DESY, Zeuthen, Germany
| | - P Laycock
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S H Lee
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - S Levonian
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - W Li
- Rice University, Houston, Texas 77005-1827, USA
| | - J Lin
- Rice University, Houston, Texas 77005-1827, USA
| | - K Lipka
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B List
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J List
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | | | | | - H-U Martyn
- I. Physikalisches Institut der RWTH, Aachen, Germany
| | - S J Maxfield
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A Mehta
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A B Meyer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Meyer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Mikocki
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - M M Mondal
- Stony Brook University, Stony Brook, New York 11794, USA
| | - A Morozov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - K Müller
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - B Nachman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Th Naumann
- Deutsches Elektronen-Synchrotron DESY, Zeuthen, Germany
| | - P R Newman
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - C Niebuhr
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - G Nowak
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - J E Olsson
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - D Ozerov
- Paul Scherrer Institut, Villigen, Switzerland
| | - S Park
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C Pascaud
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - G D Patel
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - A Petrukhin
- Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - I Picuric
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - D Pitzl
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - R Polifka
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - S Preins
- University of California, Riverside, California 92521, USA
| | - V Radescu
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - N Raicevic
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - T Ravdandorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - P Reimer
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - E Rizvi
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - P Robmann
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - R Roosen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A Rostovtsev
- Institute for Information Transmission Problems RAS, Moscow, Russia
| | - M Rotaru
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | - D P C Sankey
- STFC, Rutherford Appleton Laboratory, Didcot, Oxfordshire, United Kingdom
| | - M Sauter
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - E Sauvan
- LAPP, Université de Savoie, CNRS/IN2P3, Annecy-le-Vieux, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S Schmitt
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B A Schmookler
- Stony Brook University, Stony Brook, New York 11794, USA
| | | | - A Schöning
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - F Sefkow
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Shushkevich
- Lomonosov Moscow State University, Skobeltsyn Institute of Nuclear Physics, Moscow, Russia
| | - Y Soloviev
- Lebedev Physical Institute, Moscow, Russia
| | - P Sopicki
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - D South
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - V Spaskov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - A Specka
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - M Steder
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B Stella
- Dipartimento di Fisica Università di Roma Tre and INFN Roma 3, Roma, Italy
| | - U Straumann
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - C Sun
- Shandong University, Shandong, People's Republic of China
| | - T Sykora
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - P D Thompson
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - D Traynor
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - B Tseepeldorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
- Ulaanbaatar University, Ulaanbaatar, Mongolia
| | - Z Tu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Valkárová
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - C Vallée
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - P Van Mechelen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - D Wegener
- Institut für Physik, TU Dortmund, Dortmund, Germany
| | - E Wünsch
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Žáček
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - J Zhang
- Shandong University, Shandong, People's Republic of China
| | - Z Zhang
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - R Žlebčík
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | | | - F Zomer
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| |
Collapse
|
3
|
Lauber S, Aulenbacher K, Barth W, Basten M, Burandt C, Dziuba F, Forck P, Gettmann V, Heilmann M, Kürzeder T, List J, Miski-Oglu M, Podlech H, Rubin A, Schwarz M, Sieber T, Yaramyshev S. A dynamic collimation and alignment system for the Helmholtz linear accelerator. Rev Sci Instrum 2021; 92:113306. [PMID: 34852560 DOI: 10.1063/5.0069824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Accepted: 11/02/2021] [Indexed: 06/13/2023]
Abstract
The upcoming commissioning of the superconducting (SC) continuous wave Helmholtz linear accelerators first of series cryomodule is going to demand precise alignment of the four internal SC cavities and two SC solenoids. For optimal results, a beam-based alignment method is used to reduce the misalignment of the whole cryomodule, as well as its individual components. A symmetric beam of low transverse emittance is required for this method, which is to be formed by a collimation system. It consists of two separate plates with milled slits, aligned in the horizontal and vertical direction. The collimation system and alignment measurements are proposed, investigated, and realized. The complete setup of this system and its integration into the existing environment at the GSI High Charge State Injector are presented, as well as the results of the recent reference measurements.
Collapse
Affiliation(s)
- S Lauber
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | | | - W Barth
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | - M Basten
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | - C Burandt
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | - F Dziuba
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | - P Forck
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - V Gettmann
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - M Heilmann
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - T Kürzeder
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | - J List
- Helmholtz Institute Mainz, Mainz 55128, Germany
| | | | - H Podlech
- IAP, Goethe University Frankfurt, Frankfurt 60438, Germany
| | - A Rubin
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - M Schwarz
- IAP, Goethe University Frankfurt, Frankfurt 60438, Germany
| | - T Sieber
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| | - S Yaramyshev
- GSI Helmholtz Center for Heavy Ion Research, Darmstadt 64291, Germany
| |
Collapse
|
4
|
Andreev V, Baghdasaryan A, Begzsuren K, Belousov A, Bertone V, Bolz A, Boudry V, Brandt G, Brisson V, Britzger D, Buniatyan A, Bylinkin A, Bystritskaya L, Campbell AJ, Cantun Avila KB, Cerny K, Chekelian V, Contreras JG, Cvach J, Currie J, Dainton JB, Daum K, Diaconu C, Dobre M, Dodonov V, Eckerlin G, Egli S, Elsen E, Favart L, Fedotov A, Feltesse J, Fleischer M, Fomenko A, Gabathuler E, Gayler J, Gehrmann T, Ghazaryan S, Goerlich L, Gogitidze N, Gouzevitch M, Grab C, Grebenyuk A, Greenshaw T, Grindhammer G, Gwenlan C, Haidt D, Henderson RCW, Hladkỳ J, Hoffmann D, Horisberger R, Hreus T, Huber F, Huss A, Jacquet M, Janssen X, Jung AW, Jung H, Kapichine M, Katzy J, Kiesling C, Klein M, Kleinwort C, Kogler R, Kostka P, Kretzschmar J, Krücker D, Krüger K, Landon MPJ, Lange W, Laycock P, Lebedev A, Levonian S, Lipka K, List B, List J, Lobodzinski B, Malinovski E, Martyn HU, Maxfield SJ, Mehta A, Meyer AB, Meyer H, Meyer J, Mikocki S, Morozov A, Müller K, Naumann T, Newman PR, Niebuhr C, Niehues J, Nowak G, Olsson JE, Ozerov D, Pascaud C, Patel GD, Perez E, Petrukhin A, Picuric I, Pirumov H, Pitzl D, Plačakytė R, Polifka R, Rabbertz K, Radescu V, Raicevic N, Ravdandorj T, Reimer P, Rizvi E, Robmann P, Roosen R, Rostovtsev A, Rotaru M, Šálek D, Sankey DPC, Sauter M, Sauvan E, Schmitt S, Schoeffel L, Schöning A, Sefkow F, Shushkevich S, Soloviev Y, Sopicki P, South D, Spaskov V, Specka A, Steder M, Stella B, Straumann U, Sutton MR, Sykora T, Thompson PD, Traynor D, Truöl P, Tsakov I, Tseepeldorj B, Valkárová A, Vallée C, Van Mechelen P, Vazdik Y, Wegener D, Wünsch E, Žáček J, Zhang Z, Žlebčík R, Zohrabyan H, Zomer F. Determination of the strong coupling constant α s ( m Z ) in next-to-next-to-leading order QCD using H1 jet cross section measurements: H1 Collaboration. Eur Phys J C Part Fields 2017; 77:791. [PMID: 31997933 PMCID: PMC6956906 DOI: 10.1140/epjc/s10052-017-5314-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Accepted: 10/12/2017] [Indexed: 06/08/2023]
Abstract
The strong coupling constant α s is determined from inclusive jet and dijet cross sections in neutral-current deep-inelastic ep scattering (DIS) measured at HERA by the H1 collaboration using next-to-next-to-leading order (NNLO) QCD predictions. The dependence of the NNLO predictions and of the resulting value ofα s ( m Z ) at the Z-boson mass m Z are studied as a function of the choice of the renormalisation and factorisation scales. Using inclusive jet and dijet data together, the strong coupling constant is determined to beα s ( m Z ) = 0.1157 ( 20 ) exp ( 29 ) th . Complementary,α s ( m Z ) is determined together with parton distribution functions of the proton (PDFs) from jet and inclusive DIS data measured by the H1 experiment. The valueα s ( m Z ) = 0.1142 ( 28 ) tot obtained is consistent with the determination from jet data alone. The impact of the jet data on the PDFs is studied. The running of the strong coupling is tested at different values of the renormalisation scale and the results are found to be in agreement with expectations.
Collapse
Affiliation(s)
- V. Andreev
- Lebedev Physical Institute, Moscow, Russia
| | | | - K. Begzsuren
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | | | - V. Bertone
- Department of Physics and Astronomy, Vrije University, De Boelelaan 1081, Amsterdam, The Netherlands
- National Institute for Subatomic Physics (NIKHEF), Science Park 105, Amsterdam, The Netherlands
| | - A. Bolz
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - V. Boudry
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G. Brandt
- II. Physikalisches Institut, Universität Göttingen, Göttingen, Germany
| | - V. Brisson
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - D. Britzger
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - A. Buniatyan
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | - A. Bylinkin
- Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region Russian Federation
| | - L. Bystritskaya
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | | | | | - K. Cerny
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | | | - J. G. Contreras
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán Mexico
| | - J. Cvach
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - J. Currie
- Institute for Particle Physics Phenomenology, Ogden Centre for Fundamental Physics, Durham University, South Road, Durham, UK
| | - J. B. Dainton
- Department of Physics, University of Liverpool, Liverpool, UK
| | - K. Daum
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | - C. Diaconu
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
| | - M. Dobre
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | | | | | - S. Egli
- Paul Scherrer Institute, Villigen, Switzerland
| | | | - L. Favart
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A. Fedotov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | | | | | - A. Fomenko
- Lebedev Physical Institute, Moscow, Russia
| | - E. Gabathuler
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - T. Gehrmann
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | | | - L. Goerlich
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | | | - M. Gouzevitch
- IPNL, Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - C. Grab
- Institut für Teilchenphysik, ETH Zürich, Zurich, Switzerland
| | - A. Grebenyuk
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - T. Greenshaw
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - C. Gwenlan
- Department of Physics, Oxford University, Oxford, UK
| | | | | | - J. Hladkỳ
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - D. Hoffmann
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
| | | | - T. Hreus
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - F. Huber
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - A. Huss
- Institut für Teilchenphysik, ETH Zürich, Zurich, Switzerland
| | - M. Jacquet
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - X. Janssen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A. W. Jung
- Department of Physics and Astronomy, Purdue University, 525 Northwestern Ave, West Lafayette, IN 47907 USA
| | | | - M. Kapichine
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | - C. Kiesling
- Max-Planck-Institut für Physik, Munich, Germany
| | - M. Klein
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - R. Kogler
- Institut für Experimentalphysik, Universität Hamburg, Hamburg, Germany
| | - P. Kostka
- Department of Physics, University of Liverpool, Liverpool, UK
| | - J. Kretzschmar
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | | | - M. P. J. Landon
- School of Physics and Astronomy, Queen Mary University of London, London, UK
| | | | - P. Laycock
- Department of Physics, University of Liverpool, Liverpool, UK
| | - A. Lebedev
- Lebedev Physical Institute, Moscow, Russia
| | | | | | | | | | | | | | - H.-U. Martyn
- I. Physikalisches Institut der RWTH, Aachen, Germany
| | - S. J. Maxfield
- Department of Physics, University of Liverpool, Liverpool, UK
| | - A. Mehta
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - H. Meyer
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | | | - S. Mikocki
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | - A. Morozov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - K. Müller
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | | | - P. R. Newman
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | | | - J. Niehues
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - G. Nowak
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | | | - D. Ozerov
- Paul Scherrer Institute, Villigen, Switzerland
| | - C. Pascaud
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - G. D. Patel
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - A. Petrukhin
- IPNL, Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - I. Picuric
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | | | | | | | - R. Polifka
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
- Department of Physics, University of Toronto, Toronto, ON M5S 1A7 Canada
| | - K. Rabbertz
- Karlsruher Institut für Technologie (KIT), Institut für Experimentelle Teilchenphysik (ETP), Wolfgang-Gaede-Str. 1, Karlsruhe, Germany
| | - V. Radescu
- Department of Physics, Oxford University, Oxford, UK
| | - N. Raicevic
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - T. Ravdandorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - P. Reimer
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - E. Rizvi
- School of Physics and Astronomy, Queen Mary University of London, London, UK
| | - P. Robmann
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - R. Roosen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A. Rostovtsev
- Institute for Information Transmission Problems RAS, Moscow, Russia
| | - M. Rotaru
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | - D. Šálek
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - D. P. C. Sankey
- STFC, Rutherford Appleton Laboratory, Didcot, Oxfordshire UK
| | - M. Sauter
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - E. Sauvan
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
- LAPP, Université de Savoie, CNRS/IN2P3, Annecy-le-Vieux, France
| | | | | | - A. Schöning
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | | | - S. Shushkevich
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, Moscow, Russia
| | | | - P. Sopicki
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | | | - V. Spaskov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - A. Specka
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | | | - B. Stella
- Dipartimento di Fisica, Università di Roma Tre and INFN Roma 3, Rome, Italy
| | - U. Straumann
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - M. R. Sutton
- Department of Physics and Astronomy, University of Sussex, Pevensey II, Brighton, UK
| | - T. Sykora
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - P. D. Thompson
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | - D. Traynor
- School of Physics and Astronomy, Queen Mary University of London, London, UK
| | - P. Truöl
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - I. Tsakov
- Institute for Nuclear Research and Nuclear Energy, Sofia, Bulgaria
| | - B. Tseepeldorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
- Ulaanbaatar University, Ulaanbaatar, Mongolia
| | - A. Valkárová
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - C. Vallée
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
| | - P. Van Mechelen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - Y. Vazdik
- Lebedev Physical Institute, Moscow, Russia
| | - D. Wegener
- Institut für Physik, TU Dortmund, Dortmund, Germany
| | | | - J. Žáček
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - Z. Zhang
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | | | | | - F. Zomer
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| |
Collapse
|
5
|
Garvey W, Gaal L, Leiter L, Vijapurkar U, List J, Cuddihy R, Ren J, Davies M, Fegade M. Effects of canagliflozin versus glimepiride on adipokines, inflammatory biomarkers, and chemokines in patients with type 2 diabetes mellitus. Indian Heart J 2017. [DOI: 10.1016/j.ihj.2017.09.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
6
|
List J, Gordon G, Csordas A, Stavas J. Radiation exposure during chronic central venous occlusion interventions in the interventional radiology suite: A simulation study comparing two disposable radiation protection devices. J Vasc Interv Radiol 2017. [DOI: 10.1016/j.jvir.2016.12.1157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
7
|
List J, Gordon G, Csordas A, Stavas J. A uterine artery embolization simulation study comparing the scatter radiation reduction to the operator with two disposable radiation protection devices. J Vasc Interv Radiol 2017. [DOI: 10.1016/j.jvir.2016.12.636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
8
|
Wilke S, List J, Mekle R, Lindenberg R, Bukowski M, Ott S, Schubert F, Flöel A. EP 138. Impact of recurrent mild traumatic brain injury on GABA concentration and GABAB receptor activity. Clin Neurophysiol 2016. [DOI: 10.1016/j.clinph.2016.05.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Sonesson C, Frederich R, Johansson P, Gause-Nilsson I, Langkilde AM, List J, Rohwedder K. Kardiovaskuläre Verträglichkeit von Dapagliflozin bei Patienten mit Typ-2-Diabetes-mellitus (T2DM) und unterschiedlichen Ausprägungen des kardiovaskulären Risikos. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
10
|
Pietrini S, Durst M, Schubert J, List J, Wong G, Fullner J. Do one, do one, do one: a model for an inexpensive, build-it-yourself IR simulation laboratory. J Vasc Interv Radiol 2016. [DOI: 10.1016/j.jvir.2015.12.600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
11
|
Leitner GC, List J, Horvath M, Eichelberger B, Panzer S, Jilma-Stohlawetz P. Additive solutions differentially affect metabolic and functional parameters of platelet concentrates. Vox Sang 2015; 110:20-6. [DOI: 10.1111/vox.12317] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2015] [Revised: 06/14/2015] [Accepted: 06/25/2015] [Indexed: 11/28/2022]
Affiliation(s)
- G. C. Leitner
- Department of Blood Group Serology and Transfusion Medicine; Medical University; Vienna Austria
| | - J. List
- Department of Hematology; Hanuschkrankenhaus; Vienna Austria
| | - M. Horvath
- Department of Blood Group Serology and Transfusion Medicine; Medical University; Vienna Austria
| | - B. Eichelberger
- Department of Blood Group Serology and Transfusion Medicine; Medical University; Vienna Austria
| | - S. Panzer
- Department of Blood Group Serology and Transfusion Medicine; Medical University; Vienna Austria
| | | |
Collapse
|
12
|
Moortgat-Pick G, Baer H, Battaglia M, Belanger G, Fujii K, Kalinowski J, Heinemeyer S, Kiyo Y, Olive K, Simon F, Uwer P, Wackeroth D, Zerwas PM, Arbey A, Asano M, Bagger J, Bechtle P, Bharucha A, Brau J, Brümmer F, Choi SY, Denner A, Desch K, Dittmaier S, Ellwanger U, Englert C, Freitas A, Ginzburg I, Godfrey S, Greiner N, Grojean C, Grünewald M, Heisig J, Höcker A, Kanemura S, Kawagoe K, Kogler R, Krawczyk M, Kronfeld AS, Kroseberg J, Liebler S, List J, Mahmoudi F, Mambrini Y, Matsumoto S, Mnich J, Mönig K, Mühlleitner MM, Pöschl R, Porod W, Porto S, Rolbiecki K, Schmitt M, Serpico P, Stanitzki M, Stål O, Stefaniak T, Stöckinger D, Weiglein G, Wilson GW, Zeune L, Moortgat F, Xella S, Bagger J, Brau J, Ellis J, Kawagoe K, Komamiya S, Kronfeld AS, Mnich J, Peskin M, Schlatter D, Wagner A, Yamamoto H. Physics at the [Formula: see text] linear collider. Eur Phys J C Part Fields 2015; 75:371. [PMID: 26300691 PMCID: PMC4537698 DOI: 10.1140/epjc/s10052-015-3511-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/25/2015] [Accepted: 05/09/2015] [Indexed: 06/04/2023]
Abstract
A comprehensive review of physics at an [Formula: see text] linear collider in the energy range of [Formula: see text] GeV-3 TeV is presented in view of recent and expected LHC results, experiments from low-energy as well as astroparticle physics. The report focusses in particular on Higgs-boson, top-quark and electroweak precision physics, but also discusses several models of beyond the standard model physics such as supersymmetry, little Higgs models and extra gauge bosons. The connection to cosmology has been analysed as well.
Collapse
Affiliation(s)
- G. Moortgat-Pick
- />II. Institute of Theoretical Physics, University of Hamburg, 22761 Hamburg, Germany
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - H. Baer
- />Department of Physics and Astronomy, University of Oklahoma, Norman, OK 73019 USA
| | - M. Battaglia
- />Santa Cruz Institute for Particle Physics, University of California Santa Cruz, Santa Cruz, CA USA
| | - G. Belanger
- />Laboratoire de Physique Theorique (LAPTh), Université Savoie Mont Blanc, CNRS, B.P.110, 74941 Annecy-le-Vieux, France
| | - K. Fujii
- />High Energy Accelerator Research Organisation (KEK), Tsukuba, Japan
| | - J. Kalinowski
- />Faculty of Physics, University of Warsaw, 02093 Warsaw, Poland
| | - S. Heinemeyer
- />Instituto de Física de Cantabria (CSIC-UC), 39005 Santander, Spain
| | - Y. Kiyo
- />Department of Physics, Juntendo University, Inzai, Chiba 270-1695 Japan
| | - K. Olive
- />William I. Fine Theoretical Physics Institute, School of Physics and Astronomy, University of Minnesota, Minneapolis, MN 55455 USA
| | - F. Simon
- />Max-Planck-Institut für Physik, 80805 Munich, Germany
| | - P. Uwer
- />Humboldt-Universität zu Berlin, Institut für Physik, 12489 Berlin, Germany
| | - D. Wackeroth
- />Department of Physics, SUNY at Buffalo, Buffalo, NY 14260-1500 USA
| | - P. M. Zerwas
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - A. Arbey
- />Université de Lyon, Université Lyon 1, 69622 Villeurbonne Cedex, France
- />Centre de Recherche Astrophysique de Lyon, CNRS, UMR 5574, 69561 Saint-Genis Laval Cedex, France
- />Ecole Normale Supérieure de Lyon, Lyon, France
| | - M. Asano
- />Physikalisches Institut and Bethe Center for Theoretical Physics, Universität Bonn, 53115 Bonn, Germany
| | - J. Bagger
- />Department of Physics and Astronomy, Johns Hopkins University, Baltimore, MD 21218 USA
- />TRIUMF, Vancouver, BC V6T 2A3 Canada
| | - P. Bechtle
- />Physikalisches Institut, University of Bonn, Bonn, Germany
| | - A. Bharucha
- />Physik Department T31, Technische Universität München, 85748 Garching, Germany
- />CNRS, Aix Marseille U., U. de Toulon, CPT, 13288 Marseille, France
| | - J. Brau
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
| | - F. Brümmer
- />LUPM, UMR 5299, Université de Montpellier II et CNRS, 34095 Montpellier, France
| | - S. Y. Choi
- />Department of Physics, Chonbuk National University, Jeonju, 561-756 Republic of Korea
| | - A. Denner
- />Universität Würzburg, Institut für Theoretische Physik und Astrophysik, 97074 Würzburg, Germany
| | - K. Desch
- />Physikalisches Institut, University of Bonn, Bonn, Germany
| | - S. Dittmaier
- />Physikalisches Institut, Albert–Ludwigs–Universität Freiburg, 79104 Freiburg, Germany
| | - U. Ellwanger
- />Laboratoire de Physique, UMR 8627, CNRS, Universite de Paris-Sud, 91405 Orsay, France
| | - C. Englert
- />SUPA, School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ UK
| | - A. Freitas
- />PITT PACC, Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - I. Ginzburg
- />Sobolev Institute of Mathematics and Novosibirsk State University, Novosibirsk, 630090 Russia
| | - S. Godfrey
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, K1S 5B6 Canada
| | - N. Greiner
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
- />Max-Planck-Institut für Physik, 80805 Munich, Germany
| | - C. Grojean
- />ICREA at IFAE, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain
| | | | - J. Heisig
- />Institute for Theoretical Particle Physics and Cosmology, RWTH Aachen University, 52056 Aachen, Germany
| | | | - S. Kanemura
- />Department of Physics, University of Toyama, 3190 Gofuku, Toyama, 930-8555 Japan
| | - K. Kawagoe
- />Department of Physics, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581 Japan
| | - R. Kogler
- />University of Hamburg, Hamburg, Germany
| | - M. Krawczyk
- />Faculty of Physics, University of Warsaw, 02093 Warsaw, Poland
| | - A. S. Kronfeld
- />Theoretical Physics Department, Fermi National Accelerator Laboratory, Batavia, IL USA
- />Institute for Advanced Study, Technische Universität München, 85748 Garching, Germany
| | - J. Kroseberg
- />Physikalisches Institut, University of Bonn, Bonn, Germany
| | - S. Liebler
- />II. Institute of Theoretical Physics, University of Hamburg, 22761 Hamburg, Germany
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - J. List
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - F. Mahmoudi
- />Université de Lyon, Université Lyon 1, 69622 Villeurbonne Cedex, France
- />Centre de Recherche Astrophysique de Lyon, CNRS, UMR 5574, 69561 Saint-Genis Laval Cedex, France
- />Ecole Normale Supérieure de Lyon, Lyon, France
| | - Y. Mambrini
- />Laboratoire de Physique, UMR 8627, CNRS, Universite de Paris-Sud, 91405 Orsay, France
| | - S. Matsumoto
- />Kavli IPMU (WPI), The University of Tokyo, Kashiwa, Chiba 277-8583 Japan
| | - J. Mnich
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - K. Mönig
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - M. M. Mühlleitner
- />Institute for Theoretical Physics, Karlsruhe Institute of Technology, 76128 Karlsruhe, Germany
| | - R. Pöschl
- />Laboratoire de L’accelerateur Lineaire (LAL), CNRS/IN2P3, Orsay, France
| | - W. Porod
- />Universität Würzburg, Institut für Theoretische Physik und Astrophysik, 97074 Würzburg, Germany
| | - S. Porto
- />II. Institute of Theoretical Physics, University of Hamburg, 22761 Hamburg, Germany
| | - K. Rolbiecki
- />Faculty of Physics, University of Warsaw, 02093 Warsaw, Poland
- />Instituto de Fisica Teorica, IFT-UAM/CSIC, Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| | - M. Schmitt
- />Department of Physics and Astronomy, Northwestern University, Evanston, IL 60091 USA
| | - P. Serpico
- />Laboratoire de Physique Theorique (LAPTh), Université Savoie Mont Blanc, CNRS, B.P.110, 74941 Annecy-le-Vieux, France
| | - M. Stanitzki
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - O. Stål
- />The Oskar Klein Centre, Department of Physics, Stockholm University, 106 91 Stockholm, Sweden
| | - T. Stefaniak
- />Santa Cruz Institute for Particle Physics, University of California Santa Cruz, Santa Cruz, CA USA
| | - D. Stöckinger
- />Institut für Kern- und Teilchenphysik, TU Dresden, 01069 Dresden, Germany
| | - G. Weiglein
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - G. W. Wilson
- />Department of Physics and Astronomy, University of Kansas, Lawrence, KS 66045 USA
| | - L. Zeune
- />ITFA, University of Amsterdam, Science Park 904, 1018 XE Amsterdam, The Netherlands
| | | | - S. Xella
- />Niels Bohr Institute, University of Copenhagen, Kobenhavn, Denmark
| | - J. Bagger
- />Department of Physics and Astronomy, Johns Hopkins University, Baltimore, MD 21218 USA
- />TRIUMF, Vancouver, BC V6T 2A3 Canada
| | - J. Brau
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
| | - J. Ellis
- />CERN, Geneva, Switzerland
- />Theoretical Particle Physics and Cosmology Group, Department of Physics, King’s College London, Strand, London WC2R 2LS UK
| | - K. Kawagoe
- />Department of Physics, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581 Japan
| | - S. Komamiya
- />Department of Physics, Graduate School of Science, and International Center for Elementary Particle Physics, The University of Tokyo, Tokyo, 113-0033 Japan
| | - A. S. Kronfeld
- />Theoretical Physics Department, Fermi National Accelerator Laboratory, Batavia, IL USA
- />Institute for Advanced Study, Technische Universität München, 85748 Garching, Germany
| | - J. Mnich
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
| | - M. Peskin
- />SLAC, Stanford University, Menlo Park, CA, 94025 USA
| | | | - A. Wagner
- />Deutsches Elektronen Synchrotron (DESY), Hamburg und Zeuthen, 22603 Hamburg, Germany
- />University of Hamburg, Hamburg, Germany
| | - H. Yamamoto
- />Department of Physics, Tohoku University, Sendai, Miyagi Japan
| |
Collapse
|
13
|
List J, Lesemann A, Kubke JC, Kulzow N, Schreiber SJ, Floel A. Impact of tDCS on cerebral autoregulation in aging and in patients with cerebrovascular diseases. Neurology 2015; 84:626-8. [DOI: 10.1212/wnl.0000000000001230] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
14
|
Sekandi JN, List J, Luzze H, Yin XP, Dobbin K, Corso PS, Oloya J, Okwera A, Whalen CC. Yield of undetected tuberculosis and human immunodeficiency virus coinfection from active case finding in urban Uganda. Int J Tuberc Lung Dis 2014; 18:13-9. [PMID: 24365547 DOI: 10.5588/ijtld.13.0129] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
OBJECTIVES To determine the yield of undetected active tuberculosis (TB), TB and human immunodeficiency virus (HIV) coinfection and the number needed to screen (NNS) to detect a case using active case finding (ACF) in an urban community in Kampala, Uganda. METHODS In a door-to-door survey conducted in Rubaga community from January 2008 to June 2009, residents aged ≥15 years were screened for chronic cough (≥2 weeks) and tested for TB disease using smear microscopy and/or culture. Rapid testing was used to screen for HIV infection. The NNS to detect one case was calculated based on population screened and undetected cases found. RESULTS Of 5102 participants, 3868 (75.8%) were females; the median age was 24 years (IQR 20-30). Of 199 (4%) with chronic cough, 160 (80.4%) submitted sputum, of whom 39 (24.4%, 95%CI 17.4-31.5) had undetected active TB and 13 (8.1%, 95%CI 6.7-22.9) were TB-HIV co-infected. The NNS to detect one TB case was 131 in the whole study population, but only five among the subgroup with chronic cough. CONCLUSION ACF obtained a high yield of previously undetected active TB and TB-HIV cases. The NNS in the general population was 131, but the number needed to test in persons with chronic cough was five. These findings suggest that boosting the identification of persons with chronic cough may increase the overall efficiency of TB case detection at a community level.
Collapse
Affiliation(s)
- J N Sekandi
- College of Public Health, University of Georgia, Athens, Georgia, USA; and School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
| | - J List
- Yale Primary Care Program, Yale University School of Medicine, New Haven, Connecticut, USA
| | - H Luzze
- Department of Clinical Services, Ministry of Health, Kampala, Uganda
| | - X-P Yin
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - K Dobbin
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - P S Corso
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - J Oloya
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - A Okwera
- National TB Treatment Center, School of Medicine, Makerere University, Mulago, Uganda
| | - C C Whalen
- College of Public Health, University of Georgia, Athens, Georgia, USA
| |
Collapse
|
15
|
de Bruin TWA, Fioretto P, Johnsson E, Ptasynska A, Parikh SJ, List J, Rohwedder K. Sicherheit und Wirksamkeit des SGLT-2-Hemmers Dapagliflozin bei älteren Patienten mit Typ-2-Diabetes. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
List J, Lambers Heerspink HJ, de Zeeuw D, Wei L, Rohwedder K. Dapagliflozin – ein blutzuckersenkendes Medikament mit diuretischen Eigenschaften bei Typ-2-Diabetikern. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
17
|
Hardy E, Ptasynska A, de Bruin TWA, Johnsson E, Parikh SJ, List J, Rohwedder K. Veränderungen des Lipidprofils bei Patienten mit Typ-2-Diabetes mellitus unter einer Behandlung mit Dapagliflozin. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
18
|
Rohwedder K, Ptasynska A, Henry RR, Murray AV, Nauck M, Johnsson E, List J, Parikh SJ. Direkter Vergleich zeigt ähnliche Wirksamkeit von Dapagliflozin im Vergleich zu Metformin oder Sulfonylharnstoffen in verschiedenen Ausgangs-HbA1c-Gruppen. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
19
|
Sekandi JN, List J, Luzze H, Yin X, Dobbin K, Corso PS, Oloya J, Okwera A, Whalen CC. In reply to 'Active case finding for tuberculosis: what is the most informative measure for policy makers?'. Int J Tuberc Lung Dis 2014; 18:377-8. [PMID: 24670580 DOI: 10.5588/ijtld.13.0924-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- J N Sekandi
- College of Public Health, University of Georgia, Athens, Georgia, USA; School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
| | - J List
- Yale Primary Care Program, Yale University School of Medicine, New Haven, Connecticut, USA
| | - H Luzze
- Department of Clinical Services, Ministry of Health, Kampala, Uganda
| | - X Yin
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - K Dobbin
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - P S Corso
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - J Oloya
- College of Public Health, University of Georgia, Athens, Georgia, USA
| | - A Okwera
- National TB Treatment Center, School of Medicine, Makerere University, Mulago, Uganda
| | - C C Whalen
- College of Public Health, University of Georgia, Athens, Georgia, USA
| |
Collapse
|
20
|
Ott S, Bukowski M, Lindenberg R, List J, Flöel A. Motorisches Lernen und neuropsychologische Tests bei Patienten mit wiederholten Schädelhirntraumata. KLIN NEUROPHYSIOL 2014. [DOI: 10.1055/s-0034-1371217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
21
|
Lesemann A, List J, Floeel A. P 94. Influence of transcranial direct current stimulation on cortical plasticity and on cholinergic cortical activity in Alzheimer’s disease. Clin Neurophysiol 2013. [DOI: 10.1016/j.clinph.2013.04.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
22
|
Lambers Heerspink HJ, de Zeeuw D, Wie L, Leslie B, List J. Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab 2013; 15:853-62. [PMID: 23668478 PMCID: PMC3906841 DOI: 10.1111/dom.12127] [Citation(s) in RCA: 595] [Impact Index Per Article: 54.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/18/2013] [Revised: 03/21/2013] [Accepted: 05/08/2013] [Indexed: 12/11/2022]
Abstract
AIMS Sodium-glucose co-transporter 2 (SGLT2) reabsorbs glucose and sodium in the renal proximal tubule. Dapagliflozin, an SGLT2 inhibitor, targets hyperglycaemia in type 2 diabetes by increasing renal glucose excretion. To investigate whether the parallel occurring sodium loss would have diuretic-like physiologic effects, we compared dapagliflozin and hydrochlorothiazide (HCTZ) effects on 24-h blood pressure (BP), body weight, plasma volume and glomerular filtration rate (GFR). METHODS In this randomized, placebo-controlled, double-blind trial, 75 subjects with type 2 diabetes were assigned placebo, dapagliflozin 10 mg/day, or HCTZ 25 mg/day. Changes from baseline BP, body weight, plasma volume and GFR were assessed after 12 weeks of treatment. RESULTS Subjects' mean age was 56 years, type 2 diabetes mellitus (T2DM) duration 6.3 years, and haemoglobin A1c (HbA1c) 7.5%. Treatment with placebo, dapagliflozin or HCTZ resulted in changes from baseline in 24-h ambulatory mean systolic blood pressure (SBP) of -0.9 (95%CI -4.2, +2.4), -3.3 (95%CI -6.8, +0.2), and -6.6 (95%CI -9.9, -3.2) mmHg, respectively at week 12, adjusted for baseline SBP. Body weight decreased with dapagliflozin and HCTZ. In a sub-study plasma volume appeared to decrease with dapagliflozin but did not change with placebo or HCTZ treatment. Dapagliflozin induced a greater reduction in GFR (-10.8%; 95%CI -14.6, -6.7) relative to placebo (-2.9%; 95% CI -6.9, +1.2) or HCTZ (-3.4%; 95%CI -7.3, +0.6). CONCLUSIONS Dapagliflozin-induced SGLT2 inhibition for 12 weeks is associated with reductions in 24-h BP, body weight, GFR and possibly plasma volume. Cumulatively, these effects suggest that dapagliflozin may have a diuretic-like capacity to lower BP in addition to beneficial effects on glycaemic control.
Collapse
Affiliation(s)
- H J Lambers Heerspink
- Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
| | | | | | | | | |
Collapse
|
23
|
Parikh S, Ptaszynska A, Chalamandaris A, Sugg J, Johnsson K, List J. Auswirkungen von Dapagliflozin auf die Nierenfunktion. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1341918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Parikh S, Johnsson K, Ptaszynska A, Apanovitch A, Sugg J, List J. Verträglichkeit von Dapagliflozin in klinischen Studien zu Typ-2-Diabetes mellitus. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1341915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
25
|
Rohwedder K, Hruba V, Salsali A, Ying L, Sugg J, List J, Parikh S. Dapagliflozin, ein selektiver SGLT-2 Hemmer, hat eine geringe Neigung Hypoglykämien zu verursachen bei Patienten mit Type 2 Diabetes. DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0032-1314559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Kolovratova V, List J, Worel N, Jilma P, Leitner G. Administration of Prednisolone intravenously or Dexamethason orally in random donors reveals equal results in granulocyte collection: a single centre experience. Vox Sang 2011; 103:75-8. [DOI: 10.1111/j.1423-0410.2011.01567.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Jilma-Stohlawetz P, Eichelberger B, List J, Jilma B, Panzer S, Leitner G. The effect of plasma removal from apheresis platelet concentrates on platelet function. Vox Sang 2011; 102:258-60. [PMID: 21923859 DOI: 10.1111/j.1423-0410.2011.01548.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The effect of plasma removal on platelet function has scarcely been investigated. Plasma removal from apheresis platelet concentrates was achieved by centrifugation at 5000 g for 6 min or 2000 g for 10 min. After resting for 1 h, platelet concentrates were resuspended in 0·9% NaCl. Platelet function was tested before centrifugation and after resuspension by multiple electrode impedance aggregometry (MEA) and light transmission aggregometry (LTA). Plasma removal resulted in 10-14% lower response to TRAP-6 by MEA using both washing procedures, whereas TRAP-6-inducible aggregation by LTA increased slightly (2-5%). Neither plasma removal method affected collagen-induced aggregation. Thus, platelet function did not deteriorate significantly by either method.
Collapse
Affiliation(s)
- P Jilma-Stohlawetz
- Clinical Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Vienna, Austria.
| | | | | | | | | | | |
Collapse
|
28
|
List J, Duning T, Meinzer M, Kurten J, Schirmacher A, Deppe M, Evers S, Young P, Floel A. Enhanced Rapid-Onset Cortical Plasticity in CADASIL as a Possible Mechanism of Preserved Cognition. Cereb Cortex 2011; 21:2774-87. [DOI: 10.1093/cercor/bhr071] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
List J, Lesemann A, Wiener E, Walter G, Hopmann D, Schreiber S, Ruprecht K. A new case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Brain 2011; 134:e185; author reply e186. [DOI: 10.1093/brain/awr035] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
List J, Duning T, Wilbers E, Kürten J, Knecht S, Flöel A. Kortikale Plastizität bei Patienten mit zerebraler Mikroangiopathie. KLIN NEUROPHYSIOL 2011. [DOI: 10.1055/s-0031-1272670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Zhang L, Feng Y, List J, Kasichayanula S, Pfister M. Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight. Diabetes Obes Metab 2010; 12:510-6. [PMID: 20518806 DOI: 10.1111/j.1463-1326.2010.01216.x] [Citation(s) in RCA: 118] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
AIM Dapagliflozin is a stable, competitive, reversible, and highly selective inhibitor of sodium-glucose co-transporter 2, the major transporter responsible for renal glucose reabsorption. With an insulin-independent mechanism of action, dapagliflozin is currently being developed for the treatment of type 2 diabetes mellitus (T2DM). This work aims to compare the efficacy of dapagliflozin, as measured by the change in hemoglobin A1c concentration (A1c) and body weight, and to determine the pharmacodynamic effects of dapagliflozin, as measured by urinary glucose excretion in early-stage and late-stage T2DM patient populations. METHODS A total of 151 early-stage patients and 58 late-stage patients with T2DM randomly assigned 10 or 20 mg once daily (QD) dapagliflozin treatment or placebo for 12 weeks from two phase 2 studies were included in the analysis. A1c, body weight, and urinary glucose were compared between the two patient populations. RESULTS Compared with the early-stage population, patients in the late-stage population had a longer duration of T2DM and higher baseline levels of A1c, body weight, fasting plasma glucose, and urinary glucose excretion. After 12 weeks of dapagliflozin treatment, A1c reduction, weight loss, and increased urinary glucose excretion from baseline were observed in both populations. Baseline A1c level impacted the A1c reduction after dapagliflozin treatment with a comparable effect in patients with early and late stage disease. Late-stage patients had greater reduction in body weight. There was no statistically significant difference in the amount of urinary glucose excretion between the early-stage and late-stage patients. CONCLUSIONS Dapagliflozin treatment at 10 and 20 mg QD for 12 weeks resulted in significant improvement in glycaemic control and body weight reduction in both early-stage and late-stage patients with T2DM. The findings suggest that dapagliflozin could be a promising treatment option for a wide range of patients with T2DM.
Collapse
Affiliation(s)
- L Zhang
- Research and Development, Bristol-Myers Squibb, Princeton, NJ, USA.
| | | | | | | | | |
Collapse
|
32
|
List J, Wilbers E, Kürten J, Albers J, Schwindt A, Flöel A. Focal cortical plasticity in patients with high-grade stenosis of the internal carotid artery. KLIN NEUROPHYSIOL 2010. [DOI: 10.1055/s-0030-1250875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Leitner GC, Dettke M, List J, Worel N, Weigel G, Fischer MB. Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use. Vox Sang 2010; 98:e284-9. [PMID: 20059756 DOI: 10.1111/j.1423-0410.2009.01300.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
BACKGROUND After large volume bone marrow (BM) harvest, donors and patients can develop severe anaemia, because collected BM can contain up to 20% of their red cell mass. In a prospective analysis, we investigated the feasibility to recover red blood cells (RBCs) from the harvested BM and investigated whether these RBC units meet the quality requirements of the European Council. PATIENTS AND METHODS From 19 patients (median age 51 yrs, range 31-77) with acute myocardial infarction, who participated in the MYSTAR study, a median volume of 1299 ml (range, 700-1870 ml) BM was collected. During BM processing, mononuclear cells (MNC) were separated using the Cobe Spectra apheresis system and the residual RBCs were collected in a separate bag. The quality of the collected RBCs was assessed by measuring LDH, free haemoglobin, potassium and lactate. Haemolysis was calculated and the intracellular concentration of ATP, ADP, AMP was determined by HPLC. RESULTS RBC units recovered from BM after MNC separation had a mean volume of 312 +/- 95 ml with a haematocrit of 47 +/- 8.9%, a haemoglobin content of 51 +/- 15 g per unit, a haemolysis of 0.15 +/- 0.005%, a pH of 6.8 +/- 0.007 and an intracellular ATP concentration of 135 pmol/10(6) RBC +/- 41, which is comparable with freshly collected packed red blood cells (PRBCs). CONCLUSION RBCs, collected from bone marrow harvests, can be used for autologous blood support to minimize allogeneic blood transfusions in donors and patients after large volume BM donation.
Collapse
Affiliation(s)
- G C Leitner
- Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria.
| | | | | | | | | | | |
Collapse
|
34
|
List J, Dittrich R, Dziewas R, Ringelstein E. The „Doors of Perception” – der Einfluss der unspezifischen Thalamuskerne auf die Vigilanz. KLIN NEUROPHYSIOL 2009. [DOI: 10.1055/s-0029-1220460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
35
|
Abstract
OBJECTIVE To evaluate the efficacy and safety of once-daily saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes (T2D) and inadequate glycemic control. RESEARCH DESIGN AND METHODS This study included a main treatment cohort (MTC) with 401 patients (HbA(1c) > or = 7% and < or =10%) randomized and treated with oral saxagliptin 2.5, 5, or 10 mg once daily or placebo for 24 weeks and a separate open-label cohort (OLC) with 66 patients (HbA(1c) > 10% and < or =12%) who received saxagliptin 10 mg once daily for 24 weeks. Primary endpoint was HbA(1c) change from baseline to week 24. Secondary endpoints included change from baseline to week 24 in fasting plasma glucose (FPG), proportion of patients achieving HbA(1c) < 7%, and changes in postprandial glucose area-under-the-curve (PPG-AUC). Efficacy analyses for continuous variables were performed using an ANCOVA model with last-observation-carried-forward methodology. RESULTS In the MTC, saxagliptin demonstrated statistically significant decreases in adjusted mean HbA(1c) changes from baseline (mean, 7.9%) to week 24 (-0.43%, -0.46%, -0.54%) for saxagliptin 2.5, 5, and 10 mg, respectively, vs. +0.19% for placebo (all p < 0.0001). Adjusted mean FPG was significantly reduced from baseline (-15, -9, -17 mg/dL) for saxagliptin 2.5, 5, and 10 mg, respectively, vs. +6 mg/dL for placebo (p = 0.0002, p = 0.0074, p < 0.0001, respectively). More saxagliptin-treated patients achieved HbA(1c) < 7% at week 24 (35% [p = NS], 38% [p = 0.0443], 41% [p = 0.0133]) for saxagliptin 2.5, 5, and 10 mg, respectively, than placebo (24%). PPG-AUC was reduced for saxagliptin 2.5, 5, and 10 mg (-6868, -6896, -8084 mg x min/dL, respectively) vs. placebo (-647 mg x min/dL) with statistical significance demonstrated for saxagliptin 5 mg (p = 0.0002) and 10 mg (p < 0.0001). HbA(1c), FPG, and PPG-AUC reductions were also observed in the OLC at 24 weeks. In the MTC, adverse event frequency was similar across all study arms. No cases of confirmed hypoglycemia (symptoms, with fingerstick glucose < or =50 mg/dL) were observed in either cohort. Saxagliptin was not associated with weight gain. Study limitations included the lack of a control group for the OLC and the use of prespecified rescue criteria, which limited the exposure time during which patients could remain on their originally randomized medication without the introduction of additional antihyperglycemic rescue treatment. CONCLUSIONS Once-daily saxagliptin monotherapy for 24 weeks was generally well tolerated and demonstrated clinically meaningful reductions in key parameters of glycemic control vs. placebo. TRIAL REGISTRATION Clinical Trials NCT00121641
Collapse
Affiliation(s)
- J Rosenstock
- Dallas Diabetes and Endocrine Center at Medical City, 7777 Forest Lane, C-685, Dallas, TX 75230, USA.
| | | | | | | | | | | |
Collapse
|
36
|
List J, Kürten J, Schirmacher A, Young P, Flöel A. Fokale kortikale Plastizität bei Patienten mit zerebraler autosomal dominanter Arteriopathie mit subkortikalen Infarkten und Leukenzephalopathie (CADASIL) – eine TMS-Studie. Akt Neurol 2009. [DOI: 10.1055/s-0029-1238379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
37
|
Chacra AR, Tan GH, Apanovitch A, Ravichandran S, List J, Chen R. Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial. Int J Clin Pract 2009; 63:1395-406. [PMID: 19614786 PMCID: PMC2779994 DOI: 10.1111/j.1742-1241.2009.02143.x] [Citation(s) in RCA: 198] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
AIMS Assess the efficacy and safety of saxagliptin added to a submaximal sulphonylurea dose vs. uptitration of sulphonylurea monotherapy in patients with type 2 diabetes and inadequate glycaemic control with sulphonylurea monotherapy. METHODS AND PATIENTS A total of 768 patients (18-77 years; HbA(1c) screening >or= 7.5 to <or= 10.0%) were randomised and treated with saxagliptin 2.5 or 5 mg in combination with glyburide 7.5 mg vs. glyburide 10 mg for 24 weeks. Blinded uptitration glyburide was allowed in the glyburide-only arm to a maximum total daily dose of 15 mg. Efficacy analyses were performed using ANCOVA and last-observation-carried-forward methodology. RESULTS At week 24, 92% of glyburide-only patients were uptitrated to a total glyburide dose of 15 mg/day. Saxagliptin 2.5 and 5 mg provided statistically significant adjusted mean decreases from baseline to week 24 vs. uptitrated glyburide, respectively, in HbA(1c) (-0.54%, -0.64% vs. +0.08%; both p < 0.0001) and fasting plasma glucose (-7, -10 vs. +1 mg/dl; p = 0.0218 and p = 0.002). The proportion of patients achieving an HbA(1c) < 7% was greater for saxagliptin 2.5 and 5 mg vs. uptitrated glyburide (22.4% and 22.8% vs. 9.1%; both p < 0.0001). Postprandial glucose area under the curve was reduced for saxagliptin 2.5 and 5 mg vs. uptitrated glyburide (-4296 and -5000 vs. +1196 mg.min/dl; both p < 0.0001). Adverse event occurrence was similar across all groups. Reported hypoglycaemic events were not statistically significantly different for saxagliptin 2.5 (13.3%) and 5 mg (14.6%) vs. uptitrated glyburide (10.1%). CONCLUSION Saxagliptin added to submaximal glyburide therapy led to statistically significant improvements vs. uptitration of glyburide alone across key glycaemic parameters and was generally well tolerated.
Collapse
Affiliation(s)
- A R Chacra
- Diabetes Center, Federal University of São Paulo, São Paulo, Brazil
| | | | | | | | | | | |
Collapse
|
38
|
List J, Buckland MS, Thobhani B, Sheed CJ, Mann JC, Claxton M, Heelan B. Dark immunofluorescence: correlation with serum immunoglobulin abnormalities. Clin Vaccine Immunol 2006; 13:1294-5. [PMID: 16971516 PMCID: PMC1656544 DOI: 10.1128/cvi.00218-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Occasional serum samples (<0.5%) tested by indirect immunofluorescence showed less fluorescence than did negative-control serum. A retrospective review of these patients' serum immunoglobulins revealed a high percentage of abnormalities (71%, versus 22% of controls). We suggest that this observation should be reported when seen and that the clinician should be alerted to an association with immunoglobulin abnormalities.
Collapse
Affiliation(s)
- J List
- Department of Haematology Immunology Section, Colchester General Hospital, Turner Road, Colchester, Essex CO4 5JL, United Kingdom.
| | | | | | | | | | | | | |
Collapse
|
39
|
Mayer HM, List J, Korge A, Wiechert K. [Microsurgery of acquired degenerative lumbar spinal stenosis. Bilateral over-the-top decompression through unilateral approach]. Orthopade 2004; 32:889-95. [PMID: 14579021 DOI: 10.1007/s00132-003-0536-9] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Degenerative lumbar spinal stenosis is diagnosed with an increasing incidence. Clinical and radiological signs of progression often result in a significant decrease in the patient's quality of life. The indication for surgical treatment follows the spectrum of clinical symptoms. In cases with "structural" spinal stenosis and predominant "leg symptoms" such as neurogenic claudication and/or radicular symptoms, decompressive types of surgery are indicated. However, due to the multimorbidity of the mostly elderly patients, the surgical risk should be as low as possible whereas the surgical efficacy should be as high as possible. We describe a microsurgical technique, which can achieve a bilateral decompression of the central and lateral lumbar spinal canal through a unilateral surgical approach. In a consecutive series of 275 patients, a significant increase in standing time and walking distance could be attained. The surgical complication rate was low. A complete decompression of the spinal canal with preservation of the "tension band" of the posterior spinal column could be achieved. Although this type of surgery is adequate for patients with "predominantly leg symptoms" only, low back pain improved as well in nearly 50% of the patients. However, in cases with dynamic spinal stenosis and/or disturbed curvature with predominant low back pain, a combination of the described procedure with stabilizing surgery (spinal fusion, dynamic fixation etc.) is recommended.
Collapse
Affiliation(s)
- H M Mayer
- Wirbelsäulenzentrum München, Orthopädische Klinik, Orthozentrum München, Munich.
| | | | | | | |
Collapse
|
40
|
Wiesspeiner G, Ladstätter M, List J, Luber B, Eder M. MICRO MONITOR - EIN NEUES WERKZEUG FÜR MESSUNGEN IN DER BIOMEDIZINISCHEN TECHNIK. BIOMED ENG-BIOMED TE 2003. [DOI: 10.1515/bmte.2003.48.s1.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
41
|
Fleury PA, List J. Kneader-reactor for Continuous Polymerisations Producing Solid Granular Polymers. CHEM-ING-TECH 2001. [DOI: 10.1002/1522-2640(200106)73:6<674::aid-cite6741111>3.0.co;2-g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
42
|
Abstract
Proviral integration is thought to be an obligate step of the retroviral replication cycle but the lentivirus visna has been reported to replicate in sheep choroid plexus (SCP) cultures in the absence of proviral integration. Because of new evidence that visna virus has a functional integrase, we reexamined visna virus infection of SCP cultures and found that proviral integration does indeed occur in this setting. While the majority of viral DNA remains unintegrated, integrated proviruses arise early in infection and accumulate over time. The sequences of the resulting host-virus DNA junctions show that, like other retroviruses, visna loses terminal nucleotides from its DNA upon integration. However, unlike other retroviruses, in over half the host-U3 junctions analyzed only a single nucleotide was lost such that the universally conserved CA dinucleotide, two nucleotides from the end of unintegrated viral DNA, did not directly abut host sequences in the provirus. We analyzed the role of integration in visna replication by introducing a series of five mutations into the integrase gene of molecularly cloned visna virus LV1-1KS1. Each mutation abolished viral replication, suggesting that integration may be an obligatory step in replication. We also documented productive infection of SCP cultures in which cell division had been blocked by g-irradiation. The ability of visna to integrate and to replicate in nondividing cells points to the possible utility of visna-based vectors for gene transfer into differentiated cells.
Collapse
Affiliation(s)
- J List
- Department of Microbiology, University of Minnesota, 420 Delaware Street S.E., Minneapolis, Minnesota 55455, USA
| | | |
Collapse
|
43
|
Arnold RW, List J, Rosen CE, Johnson EH, Hoffman RO. Neonatal respiratory distress caused by cryptic dacryoceles. Alaska Med 1996; 38:86-88. [PMID: 8936696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Two cases of neonatal respiratory distress responded with treatment of bilateral dacryocele. In one case, no visible or palpable external evidence of dacryocele was present until mucopurulent discharge commenced more than a week after birth. While the incidence of typical congenital nasolacrimal duct obstruction is about 6%, dacryocele is 200 times less common.
Collapse
Affiliation(s)
- R W Arnold
- Orbit, Plastic and Neuroophthalmology Ophthalmic Associates, Anchorage, Alaska 99501-2242, USA
| | | | | | | | | |
Collapse
|
44
|
Zhang L, List J, Zhu JH, Dyballa S, Weber F, Reszka R. Expression of adhesion molecules and its regulation by TNF-A and IL-2 in human glioblastoma cell lines. J Cancer Res Clin Oncol 1995. [DOI: 10.1007/bf02572125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Derlon JM, Petit-taboué MC, Dauphin F, Courtheoux P, Chapon F, Creissard P, Darcel F, Houtteville JP, Kaschten B, Sadzot B, Stevenaert A, Tjuvajev JG, Macapinlac HA, Daghighian F, Ginos JZ, Finn RD, Jiaju Zhang MS, Beattie B, Graham M, Larson SM, Blasberg RG, Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J, Go KG, Kamman RL, Mooyaart EL, Heesters MAAM, Sijens PE, Oudksrk M, van Dijk P, Levendag PC, Vecht CJ, Metz RJ, Kennedy DN, Rosen BR, Hochberg FH, Fishman AJ, Filipek PA, Caviness VS, Gross MW, Weinzierl FX, Trappe AE, Goebel WE, Frank AM, Becker G, Krone A, Schmidt K, Hofmann E, Bogdahn U, Bencsch H, Fclber S, Finkenstedt G, Kremser C, Sfockhammer G, Aichner F, Bogdahn U, Fröhlich T, Becker G, Krone A, Schlief R, Schürmann J, Jachimczak P, Hofmann E, Roggendorf W, Roosen K, Carapella CM, Carpinelli G, Passalacqua R, Raus L, Giannini M, Mastrostefano R, Podo F, Tofani A, Maslrostefano R, Mottoles M, Ferraironi A, Scelsa MG, Oppido P, Riccio A, Maini CL, Collombier L, Taillandier L, Dcbouverie M, Laurens MH, Thouvenot P, Weber M, Bertrand A, Cruickshank GS, Patterson J, Hadley D, De Witte O, Hildebrand J, Luxen A, Goldman S, Reifenberger J, Liu L, James CD, Wechsler W, Collins VP, Fabel-Schulte K, Jachimczak P, Heßdörfer B, Baur I, Schlingensiepen KH, Ernestus RI, Brysch W, Bogdahn U, Blesch A, Bosserhoff AK, Apfel R, Lottspeich F, Jachimczak P, Büttner R, Bogdahn U, Cece R, Bockhorst K, Barajon I, Tazzari S, Cavaletti G, Torri-Tarelli L, Tredici G, Hecht B, Turc-Carel C, Atllas R, Chatel M, Gaudray P, Eis M, Gioanni J, Hecht F, Balledux J, Rothbart D, Criscuolo GR, de Campos JM, Kusak ME, Rey JA, Bello MJ, Sarasa JL, Els T, Dubois F, Blond S, Parent M, Assaker R, Gosselin P, Christiaens JL, Feld R, Moringlane JR, Steudel WI, Schaudies JR, Hoehn-Berlage M, Janka M, Tonn JC, Fischer U, Meese E, Roosen K, Remmelink M, Salmon I, Cras P, Pasteels JL, Brotchi J, Gliese M, Kiss R, Bensadoun RJ, Frenay M, Formento JL, Milano G, Lagrange JL, Grellier P, Lee JY, Ernestus RI, Riese HH, Fründ R, Cervós-Navarro J, Reutter W, Lippitz B, Scheitinger C, Scholz M, Weis J, Gilsbach JM, Füzesi L, Koochekpour S, Merzak A, Geissler A, Pilkington GJ, Sanson M, Li YJ, Hoang-Xuan K, Delattre JY, Poisson M, Hamelin R, Van de Kelft E, Dams E, Martin JJ, Woertgen C, Willems P, Lehrke R, Voges J, Treuer H, Erdmann J, Müller RP, Sturm V, Wurm RE, Warrington AP, Laing RW, Holzschuh M, Sardell S, Hines F, Graham JD, Brada M, Ushio Y, Kuratsu JI, Kochi M, Kitz K, Aichholzer M, Rössler K, Goldman S, Alesch F, Ertl A, Sorensen PS, Helweg-Larsen S, Mourldsen H, Hansen HH, El Sharoum SY, Berfelo MW, Theunissen PHMH, Jager JJ, Levivier M, de Jong JMA, Fedorcsák I, Nyáry I, Osztie É, Horvath Á, Kontra G, Frenay M, Burgoni-chuzel J, Paquis P, Lagrange JL, Pirotte B, Helweg-Larsen S, Hansen SW, Sørensen PS, Salmon I, Kiss R, Krauseneck P, Müller B, Morche M, Tonn JC, Lagerwaard FJ, Brucher JM, Levendag PC, Eijkenboom WMH, Schmilz PIM, Lentzsch S, Weber F, Franke J, Dörken B, Lunardi P, Schettini G, Osman FJ, Luxen A, Qasho R, Mocellini C, Ruda R, Soffietti R, Garabello D, Sales S, De Lucchi R, Vasario E, Schiffer D, Muracciole X, Brotchi J, Régis J, Manera L, Peragut JC, Juin P, Sedan R, Nieder C, Niewald M, Walter K, Schnabel K, Nieder C, Hildebrand J, Niewald N, Nestle U, Schnabel K, Berberich W, Oschmann P, Theißen RD, Reuner KH, Kaps M, Dorndorf W, Martin KK, Hausmann O, Akinwunmi J, Rooprai HK, Kennedy A, Linke A, Ognjenovic N, Pilkington GJ, Svadovsky AI, Peresedov VV, Bulakov AA, Butyalko MY, Merlo A, Zhirnova IG, Labunsky DA, Gnazdizky VV, Gannushkina IV, Taphoorn MJB, Potman R, Barkhof F, Weerts JG, Karim ABMF, Heimans JJ, Jerrnann E, van de Pol M, van Aalst VC, Wilmink JT, Twijnstra A, van der Sande JJ, Boogerd W, Kröger R, Jäger A, Wismeth C, Dekant A, Uirich J, Brysch W, Schlingensiepen KH, Jachimczak P, Bogdahn U, Pirolte B, Cool V, Gérard C, Levivier M, Dargent JL, Goldman S, Chiquet-Ehrismann R, Brotchi J, Hildebrand J, Velu T, Herrlinger U, Schabet M, Ohneseit P, Buchholz R, Zhu J, Reszka R, Weber F, Müller J, Walther W, Zhang LI, Brock M, Roosen N, Rock JP, Zeng H, Feng J, Fenstermacher JD, Rosenblum ML, Siegal T, Mäcke H, Gabizon A, Beljanski M, Crochet S, Bergenheim AT, Zackrisson B, Elfverson J, Bergström P, Henriksson R, Butti G, Baetta R, Gratzl O, Magrassi L, De Renzis MR, Soma MR, Davegna C, Pezzotta S, Paoletti R, Fumagalli R, Infuso L, Sankar AA, Darling JL, Herholz K, Thomas DGT, Defer GL, Brugières P, Gray F, Chomienne C, Poirier J, Degos L, Degos JD, Colombo BM, DiDonato S, Ghaemi M, Finocchiaro G, Hebeda KM, Sterenborg HJCM, Saarnak AE, Wolbers JG, van Gemert MJC, Kaaijk P, Troost D, Leenstra S, Das PK, Würker M, Bosch DA, Kostron H, Hochleitner BW, Obwegeser A, Ortler M, Seiwald M, Vooys W, Krouwer HGJ, de Gast GC, Marx JJM, Pietrzyk U, Osman FJ, Lunardi P, Puzzilli F, Menovsky T, Beek JF, Wolbers JG, van Gemert MJC, Naujocks G, Wiestler OD, Schirrmacher V, Heiss WD, Schramm J, Schmitz A, Eis-Hübinger AM, Piepmeier PH, Pedersen P, Greer C, Quigley MR, Shih T, Elrifal A, Rothfus W, Kotitschke K, Maroon JC, Rohertson L, Rampling R, Whoteley TL, Piumb JA, Kerr DJ, Falina PA, Crossan IM, Roosen N, Rock JP, Brandl M, Feng J, Zeng H, Ho KL, Fenstermacher JD, Rosenblum ML, Ruchoux MM, Vincent S, Jonca F, Plouet J, Lecomte M, Tonn JC, Samid D, Thibault A, Ram Z, Oldfield EH, Myers CE, Reed E, Schabet M, Herrlinger U, Buchholz R, Shoshan Y, Haase A, Siegal T, Siegal T, Shezen E, Siegal T, Stockhammer G, Rosenblum M, Samid D, Lieberman F, Terzis AJA, Bjerkvig R, Bogdahn U, Laerum OD, Arnold H, Thibault A, Samid D, Figg WD, Myers CE, Reed E, Thomas R, Flux G, Chittenden S, Kotitschke K, Doshi P, Brazil L, Thomas DGT, Bignor D, Zalutsky M, Brada M, Tjuvajev J, Kaplitt M, Desai R, Bradley MS, Muigg S, Bettie BS, Gansbacher B, Blasberg R, Haugland HK, Saraste J, Rooseni K, Laerum OD, Vincent AJPE, Avezaat CJJ, Bout A, Felber S, Noteboom JL, Vecht CH, Valerio D, Hoogerbrugge PM, Weber F, Reszka R, Zhu J, Walther W, List J, Schulz W, Aichner F, Wolbers JG, Sterenborg IIJCM, Kamphorst W, van Gemert MJC, van Alplien HAM, Salander P, Bergenheim T, Henriksson R, Grant R, Brazil L, Haase A, Thomas R, Guerrero D, Laing R, Ashley S, Brada M, Schmidt B, Bauer B, Grau G, Bohnstedt T, Frydrych A, Bogdahn U, Franz K, Lorenz R, Brandes A, Amanzo PD, Zampieri P, Rigon A, Scelzi E, Rotilio A, Berti F, Paccagnella A, Krone A, Fiorentino MV, Müller B, Krauseneck P, van Deventer PL, Dellemijn PLI, van den Bent MJ, Vecht CJ, Kansen PJ, Tredici G, Petruccioli NG, Becker G, Cavaletti G, Cavalletti E, Kiburg B, Müller LJ, Moorer-van Delft CM, Heimans JJ, Boer HH, Pace A, Bove L, Pietrangeli A, Woydt M, Innocenti P, Aloe A, Nardi M, Jandolo B, Kellie SJ, De Graaf SSN, Bloemhof H, Roebuck D, Dalla PL, Uges DDR, Roggendorf W, Johnston I, Besser M, Chaseling RA, Koeppen S, Gründemann S, Lossos A, Siegal T, Nitschke M, Vieregge P, Reusche E, Hofmann E, Rob P, Kömpf D, Postma TJ, Vermorken JB, Heimans JJ, Rampling RP, Dunlop DJ, Steward MS, Campbell SM, Roy S, Bogdahn U, Hilkens PHE, Verweij J, van Putten WLJ, Vecht CJ, van den Bent MJ, Hilkens PHE, Moll JWB, van der Burg MEL, Planting AST, van Putten WLJ, Roosen K, Vecht CJ, van den Bent MJ, Wondrusch E, Zifko U, Drlicek M, Liszka U, Grisold W, Zifko U, Fazeny B, Dittrich C, Lanfermann H, Wondrusch E, Grisold W, Verschuuren JJ, Meneses PI, Rosenfeld MR, Kaplitt MG, Posner JB, Dalmau J, Sillevis Smitt PAE, Manley G, Heindel W, Posner JB, Cavaletti G, Bogliun G, Margorati L, Bianchi G, Drlicek M, Liska U, Casati B, Kolig C, Grisold H, Kugel H, Graus F, Reñe R, Uchuya M, Valldeoriola F, Delattre JY, Benedetti de Cosentiro C, Ortale D, Martinez R, Lambre J, Cagnolati S, Erneslus RI, Vinai C, Salmaggi A, Nemni R, Silvani A, Forno MG, Luksch R, Confalonieri P, Boiardi A, Nitschke M, Scholz J, Röhn G, Vieregge P, Kömpf D, Hochberg FH, Pfeiffer G, Netzer J, Hansen C, Eggers C, Hagel C, Kunze K, Verschuuren JJ, Lackner K, Rosenblum MK, Lieberman FS, Posner JB, Dalmau J, Metz RJ, Kennedy DN, Pardo FS, Kutke S, Sorensen AG, Hochberg FH, Fishman AJ, Filipek PA, Rosen BR, Caviness VS, Mechtler LL, Withiam-Lench S, Shin K, Klnkel WR, Patel M, Truax B, Kinkel P, Shin K, Mechtler L, Ricci M, Pantano P, Maleci A, Pierallini S, Di Stefano D, Bozzao L, Cantore GP, Röhn G, Els T, Schröder R, Hoehn-Berlage M, Ernestus RI, Ruda R, Mocellini C, Soffietti R, Campana M, Ropolo R, Riva A, de Filippi PG, Schiffer D, Salgado D, Rodrigues M, Salgado L, Fonseca AT, Vieira MR, Bravo Marques JM, Satoh H, Uozumi T, Kiya K, Kurisu K, Arita K, Sumida M, Ikawa F, Tzuk-Shina T, Gomori JM, Rubinstein R, Lossos A, Siegal T, Vaalburg W, Paans AMJ, Willemsen ATM, van Waarde A, Pruim J, Visser GM, Go KG, Valentini S, Ting YLT, De Rose R, Chidichimo G, Corricro G, van Lcycn-Pilgram K, Erncslus RI, Klug N, van Leyen-Pilgram K, Ernestus RI, Schröder R, Klug N, Woydt M, Krone A, Tonn JC, Becker G, Neumann U, Roggendorf W, Roosen K, Plate KH, Breier G, Millaucr B, Weich HA, Ullrich A, Risau W, Roosen N, Chopra RK, Mikkelsen T, Rosenblum SD, Yan PS, Knight R, Windham J, Rosenblum ML, Schiffer D, Attanasio A, Cavalla P, Chio A, Giordana MT, Migheli A, Amberger V, Hensel T, Schwab ME, Cervoni L, Celli P, Tarantino R, Huettner C, Tonn JC, Berweiler U, Roggendorf W, Salmon I, Rorive S, Rombaut K, Pirotte B, Haot J, Brotchi J, Kiss R, Maugard-Louboutin C, Charrier J, Fayet G, Sagan C, Cuillioere P, Ricolleau G, Martin S, Menegalli-Bogeelli D, Lajat Y, Resche F, Molnàr P, Bárdos H, Ádány R, Rogers JP, Pilkington GJ, Pollo B, Giaccone G, Allegranza A, Bugiani O, Prim J, Badia J, Ribas E, Coello F, Shezen E, Lossos A, Abramsky O, Siegal T, Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF, Deeb SMA, Koreich O, Yaqub B, Moutaery KRA, Giordana MT, Cavalla P, Chio A, Marino S, Vigliani MC, Schiffer D, Deburghgraeve V, Darcel F, Gedouin D, Hassel MB, Guegan Y, Jeremic B, Grujicic D, Antunovic V, Matovic M, Shibamoto Y, Kallio M, Huhmar H, Kudoh C, Detta A, Sugiura K, Hitchcock ER, Mastrostefano R, Di Russo R, Cipriani§ M, Occhipinti EM, Conti EMS, Clowegeser A, Ortler M, Seiwald M, Kostron H, Rajan B, Ross G, Lim C, Ashlcy S, Goode D, Traish D, Brada M, Sanden GACV, Schouten LJ, Coebergh JWW, Razenberg PPA, Twijnstra A, Snilders-Keilholz A, Voormolen JHC, Hermans J, Leer JWH, Taillandier L, Baylac F, Dcbouvcrie M, Anxionnal R, Bracard S, Vignand JM, Duprcz A, Weber M, Winking M, Böker DK, Simmet T, Rothbart D, Strugar J, Balledux J, Criscuolo GR, Jachimczak P, Blesch A, Heβdörfer B, Bogdahn U, Ernestus RI, Schröder R, Klug N, Krouwer HGJ, Duinen SGV, Algra A, Zentner J, Wolf HK, Ostertun B, Hufnagel A, Campos MG, Solymosi L, Schramm J, Newlands ES, O'Reilly SM, Brampton M, Soffietti R, Chio A, Mocellini C, Ruda R, Vigliani MC, Schiffer D, Sciolla R, Seliak D, Henriksson R, Bergenheim AT, Björk P, Gunnarsson PO, Hariz M, Grant R, Collie D, Gregor A, Ebmeier KP, Jarvis G, Lander F, Cull A, Sellar R, Brada M, Thomas C, Elyan S, Hines F, Ashley S, Stenning S, Bernstein JJ, Goldberg WJ, Roelcke U, Von Ammon K, Hausmann O, Radu EW, Kaech D, Leenders KL, Fitzek MM, Aronen JE, Hochberg F, Gruber M, Schmidt E, Rosen B, Flschman A, Pardo P, Afra UMU, Sipos L, Slouik F, Boiardi A, Salmaggi A, Pozzi A, Farinotti L, Fariselli L, Silvani A, Brandes A, Scelzi E, Rigon A, Zampieri P, Pignataro M, Amanzo PD, Amista P, Rotilio A, Fiorentino MV, Thomas R, Brazil L, O'Connor AM, Ashley S, Brada M, Salvati M, Cervoni L, Puzzilli F, Cervoni L, Salvati M, Raguso M, Cruickshank GS, Duckworth R, Rumpling R, Rottuci M, Fariselli L, Boiardi A, Broggi G, Plrint NG, Sabattini E, Manetto V, Gambacorta H, Poggi S, Pileri S, Ferracini R, Grant R, Plev DV, Hopf NJ, Knosp E, Bohl J, Perncczky A, Kiss R, Salmon I, Catnby I, Dewitte O, Brotchi J, Pasteels JL, Camby I, Salmon I, Darro F, Danguy A, Brotchi J, Pasteels JL, Kiss R, Kiu MC, Lai GM, Yang TS, Ng KT, Chen JS, Chang CN, Leung WM, Ho YS, Rychter MD, Klimek A, Liberski PP, Karpinaka A, Krauseneck P, Schöffel V, Müller B, Kreth FW, Faist M, Warnke PC, Ostertag CB, Nielen KMBV, Visscr MC, Lebrun C, Lonjon M, Desjardin T, Michiels JF, Chanalet SLJL, Roche JL, Chatel M, Mastronardi L, Puzzilli F, Osman FJ, Lunardi P, Matsutani M, Ushio Y, Takakura K, Menten J, Hamers H, Ribot J, Dom R, Tcepen H, Müller B, Weidner N, Krauseneck P, Naujocks G, van Roost D, Wiestler OD, Kuncz A, Nieder C, Setzel-Sesterhein M, Niewald M, Schnabel I, O'Neill KS, Kitchen ND, Wilkins PR, Marsh HT, Pierce E, Doshi R, Deane R, Previtali S, Quattrini A, Nemni R, Ducati A, Wrabetz L, Canal N, Punt CJA, Stamatakis L, Giroux B, Rutten E, Quigley MR, Beth Sargent PAC, Flores N, Simon S, Maroon JC, Quigley MR, Beth Sargent PAC, Flores N, Maroon JC, Rocca AA, Gervasoni C, Castagna A, Picozzi P, Giugni E, Rocca AA, Tonnarelli GP, Ducati A, Mangili F, Truci G, Canal N, Giovanelli M, Roelcke U, Von Ammon K, Radu EW, Leenders KL, Sachsenheimer W, Bimmler T, Seiwald M, Eiter HRW, Ortler M, Obwegesser A, Kostron H, Steilen H, Henn W, Moringlane JR, Kolles H, Feiden W, Zang KD, Sleudel WI, Steinbrecher A, Schabet M, Heb C, Bamberg M, Dichgans J, Stragliotto G, Delattre JY, Poisson M, Zampieri P, Brandes A, Rigon A, Tosatto L, D'Amanzo P, Menicucci N, Rotilio A, Mingrino S, Steudel WI, Feld R, Henn W, Zang KD, Maire JP, Caudry M, Guerin J, Celerier D, Salem N, Demeaux H, Fahregat JF, Kusak ME, Bucno A, Albisua J, Jerez P, Sarasa JL, Garefa R, de Campos JM, Kusak ME, de Campos JM, Bueno A, García-Delgado R, Sarasa JL, García-Sola R, Lantsov AA, Shustova TI, Lcnartz D, Wellenreuther R, von Deirnling A, Köning W, Menzel J, Scarpa S, Manna A, Reale MG, Oppido PA, Carapella CM, Frati L, Valery CA, Ichen M, Foncin JP, Soubrane C, Khayat D, Philippon J, Vaz R, Cruz C, Weis S, Protopapa D, März R, Winkler PA, Reulen HJ, Bise K, Beuls E, Berg J, Deinsberger W, Böker DK, Samii M, Caudry M, Darrouzet V, Guérin J, Trouette R, Causse N, Bébéar JP, Parker F, Vallee JN, Carlier R, Zerah M, Lacroix-Jousselin C, Piepmeier JM, Kveton J, Czibulka A, Tigliev GS, Chernov MP, Maslova LN, Valdueza JM, Jänisch W, Bock A, Harms L, Bessell EM, Graus F, Punt J, Firth J, Hope T, Koriech O, Al Deeb S, Al Moutaery K, Yaqub B, Silvani A, Salmaggi A, Pozzi A, Franzini A, Boiardi A, Goldbrunner R, Warmuth-Metz M, Paulus W, Tonn JC, Roosen K, Strik II, Müller B, Markert C, Pflughaupt KW, Krauseneck P, O'Neill BP, Dinapoli RP, Voges J, Sturm V, Deuß U, Traud C, Treuer H, Lehrke R, Kim DG, Müller RP, Alexandrov YS, Moutaery K, Aabed M, Koreich O, Ross GM, Rajan B, Traish D, Ashley S, Ford D, Brada M, Schmeets ILO, Jager JJ, Pannebakker MAG, de Jong JMA, van Lindert E, Knosp E, Kitz K, Blond S, Dubois F, Assaker R, Baranzelli MC, Sleiman M, Pruvo JP, Coche-Dequeant B, Matsutani M, Takakura K, Sano K, PetriČ-Grabnar G, Jereb B, Župančič N, Koršič M, Rainov NG, Burkert W, Ushio Y, Kochi M, Itoyama Y, de Campos JM, Kusak ME, Sarasa JL, García R, Bueno A, Ferrando L, Hoang-Xuan K, Sanson M, Merel P, Delattre JY, Poisson M, Delattre O, Thomas G, Hoang-Xuan K, Delattre JY, Poisson M, Thomas G, Haritz D, Obersen B, Grochulla F, Gabel D, Haselsberger K, Radner H, Pendl G, Brada M, Laing RW, Warrington AP, Nowak PJCM, Kolkman-Deurloo IKK, Visser AG, Berge HD, Niël CGJH, Levendag PC, Bergström P, Hariz M, Löfroth PO, Bergenheim T, Henriksson R, Blond S, Assaker R, Cortet-rudelli C, Dewailly D, Coche-dequeant B, Castelain B, Dinapoli R, Shaw E, Coffey R, Earle J, Foote R, Schomberg P, Gorman D, Girard N, Courel MN, Delpech B, Haselsberger K, Friehs GM, Schröttner O, Pendl G, Pötter R, hawliczek R, Sperveslage P, Prott FJ, Wachter S, Dieckmann K, Würker M, Herholz K, Pietrzyk U, Voges J, Treuer H, Sturm V, Bauer B, Heiss WD, Jund R, Zimmermann F, Feldmann HJ, Gross MW, Kneschaurek P, Molls M, Lederman G, Lowry J, Wertheim S, Voulsinas L, Fine M, Lederman G, Lowry J, Wertheim S, Fine M, Voutsinas I, Qian G, Rashid H, Lederman G, Lowry J, Wertheim S, Fine M, Voulsinas L, Qian G, Rashid H, Moutaery K, Aabed M, Koreich O, Scerrati M, Montemaggi P, Iacoangeli M, Pompucci A, Roselli R, Trignani R, Rossi GF, Shin K, Mechtler L, West C, Grand W, Shin K, Sibata C, West C, Mechtler L, Grand W, Thomas R, Guerrero D, James N, Ashley S, Gregor A, Brada M, Voges J, Sturm V, Bramer R, Pahlke H, Lehrke R, Treuer H, Banik N, Kim DG, Hövels M, Bernsen HJJA, Rijken PFJW, Van der Sanden BPJ, Hagemeier NEM, Van der Kogel AJ, Koehler PJ, Verbiest H, Jager J, Vecht CJ, Ross GM, McIlwrath A, Brown R, Mottolesb C, Pierre'Kahn A, Croux M, Roche JL, Marchai J, Delhemes P, Tremoulet M, Stilhart B, Chazai J, Caillaud P, Ravon R, Passacha J, Bouffet E, Dirven CMF, Mooy JJA, Molenaar WM, Lewandowicz GM, Grant N, Harkness W, Hayward R, Thomas DGT, Darling JL, Delepine N, Subovici II, Cornille B, Markowska S, Alkallaf JCD, KühI J, Niethammer D, Spaar HJ, Gnekow A, Havers W, Berthold F, Graf N, Lampert F, Maass E, Mertens R, Schöck V, Aguzzi A, Boukhny A, Smirtukov S, Prityko A, Hoiodov B, Geludkova O, Nikanorov A, Levin P, Rothbart D, Balledux J, Criscuolo GR, D'haen B, Van Calenbergh F, Casaer P, Dom R, Menten J, Goffin J, Plets C, Hertel A, Hernaiz P, Seipp C, Siegler K, Baum RP, Maul FD, Schwabe D, Jacobi G, Kornhuber B, Hör G, Menten J, Casaer P, Pilkington GJ, Merzak A, Rooprai HK, Bullock P, van Domburg PHMF, Wesseling P, Thijssen HOM, Wolff JEA, Boos J, Krähling KH, Gressner-Brocks V, Jürgens H, Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M, Merzak A, Koochekpour S, Pilkington GJ, Reifenberger G. Abstracts. J Neurooncol 1994. [DOI: 10.1007/bf01070874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
46
|
Abstract
Hepatic fatty acid-binding protein (FABP) is one of several abundant proteins which may participate in fatty acid uptake and utilization. Using differential hybridization to screen for growth hormone-responsive gene products, a complementary deoxyribonucleic acid (cDNA) was isolated which proved to be a hepatic FABP cDNA fragment. Hypophysectomy caused a 60% reduction in hepatic FABP messenger ribonucleic acid (mRNA) levels in rat liver, and growth hormone administration to hypophysectomized rats resulted in restoration of the expression of hepatic FABP mRNA. Other pituitary hormones did not alter these changes in expression. The response to growth hormone occurred within 4 hours of administration. During development, expression of hepatic FABP mRNA in rat liver was low in late fetal life, with increases to 40% of adult values by day 2 of life. Significant increases to adult levels did not occur until after day 25, when weaning is essentially completed. Alteration of hepatic FABP mRNA expression by growth hormone in rat liver may be important in the complex regulation of fatty acid uptake and metabolism.
Collapse
Affiliation(s)
- S A Berry
- Department of Pediatrics, University of Minnesota, Minneapolis
| | | | | | | |
Collapse
|
47
|
List J, Moser RP, Steuer M, Loudon WG, Blacklock JB, Grimm EA. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein). Cancer Res 1992; 52:1123-8. [PMID: 1737371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Interleukin 2 (IL-2) is a potent immunostimulant that causes the release of secondary cytokines and the production of lymphokine-activated killer cells. We investigated the cellular and cytokine responses to injection of recombinant human IL-2 into the human cerebrospinal fluid of 11 patients with metastatic tumors involving the spinal or cerebral leptomeninges. After initial intraventricular IL-2 administration (1.25 x 10(5) to 2 x 10(6) Cetus units/injection), cerebrospinal fluid samples were collected at intervals from 0 to 24 h. Enzyme-linked immunosorbent assay results indicated that IL-2 levels gradually decreased during the first 24 h, with an average t1/2 between 4 and 8 h. Induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and interleukin 2 receptor (p55) was also assessed by enzyme-linked immunosorbent assay. Tumor necrosis factor alpha and interleukin 6 levels peaked at 2 to 4 h and 4 to 6 h, with concentrations between 71 to 1,714 pg/ml and 942 to 10,500 pg/ml, respectively. Interleukin 1 beta, gamma-interferon, and soluble IL-2 receptor peaked later, during 6 to 12 h; the levels achieved were 234 pg/ml, 25 NIH units/ml, and 207 units/ml, respectively. All cytokine concentrations returned to near baseline between 12 and 24 h; however, the soluble IL-2 receptor levels remained elevated. Additional observations included a rapid influx of neutrophilic leukocytes, followed by a prolonged presence of lymphocytes. These data indicate a broad and complex potential of the immune response in the central nervous system, as well as further define the cytokine cascade in response to IL-2 alone.
Collapse
Affiliation(s)
- J List
- Department of Tumor Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030
| | | | | | | | | | | |
Collapse
|
48
|
Staskus KA, Couch L, Bitterman P, Retzel EF, Zupancic M, List J, Haase AT. In situ amplification of visna virus DNA in tissue sections reveals a reservoir of latently infected cells. Microb Pathog 1991; 11:67-76. [PMID: 1665538 DOI: 10.1016/0882-4010(91)90095-r] [Citation(s) in RCA: 73] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Maedi and visna are, respectively, the pulmonary and neurological manifestations of slowly progressive infections of sheep caused by retroviruses of the lentivirus subfamily. Lentivirus infections are also persistent infections in which host defenses are generally not successful in eliminating the infectious agent because of restricted viral gene expression in many infected cells. In this report, we describe a method for amplifying and detecting viral DNA in tissue sections which has made it possible to verify experimentally the postulated existence of this reservoir of latently infected cells, as well as to estimate the actual number of cells which harbor viral genomes in infected tissues. In the discussion, we present a simple mathematical model that relates this number to the rate at which inflammatory lesions develop. This model can account for both the slow progression of natural infections and for the rapid accumulation of inflammatory foci in the high dosage experimental system analysed in our studies.
Collapse
Affiliation(s)
- K A Staskus
- Department of Microbiology, University of Minnesota Medical School, Minneapolis 55455
| | | | | | | | | | | | | |
Collapse
|
49
|
Weber F, List J, Rommel T, Menzel J, Symas J, Pohl U, Mohr H, Schmitz R, Amue B. Influence of interleukin II on xenotransplanted grade 3 to 4 glioma in nude mice. Strahlenther Onkol 1989; 165:556-8. [PMID: 2546273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- F Weber
- Department of Neurosurgery, University of Cologne
| | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Prikryl A, List J. Products based on soya lecithin. Acta Univ Carol Med (Praha) 1986; 32:93-5. [PMID: 3687620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|